secwatch.observer — SEC 8-K summary
======================================

Issuer:     GridAI Technologies Corp. (GRDX)
CIK:        0001604191
Form:       8-K
Filed at:   2024-08-15T23:59:59+00:00
Accession:  0001104659-24-089923
Event type: other_material
Sentiment:  negative
Materiality: 0.80
Item codes: 4.01, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Entero Therapeutics' auditor Forvis Mazars resigns over financial reporting reliability concerns
--------------------------------------------------------------------------------

- Forvis Mazars resigned as independent auditor on Aug 9, 2024, citing belief that cost reduction measures prevent reliable financial reporting.
- Company disagrees with auditor's belief and states it has sufficient management and governance.
- Forvis Mazars was appointed on June 1, 2024 and never issued audit reports for fiscal years 2022 and 2023.
- Board appointed Timothy R. Ramdeen as new director; he brings life science investment experience.
- Board filled audit committee vacancies: Chaitan Khosla and Alastair Riddell appointed, Edward Borkowski named Audit Chair and Compensation Committee Chair.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1604191/000110465924089923/0001104659-24-089923-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1604191/000110465924089923/tm2421756d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-089923

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer